4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
Meet Veristat at RAPS Euro Convergence 2025
Veristat is delighted to participate in RAPS Euro Convergence 2025, the leading regulatory affairs conference in Europe. The event will be held May 13–16, 2025, at the SQUARE Brussels Meeting Centre.
This premier conference unites global experts to explore cutting-edge trends and challenges in healthcare regulation, with focused sessions on devices, IVDs, pharmaceuticals, AI, software, and more.
Visit Us at Booth #20
Discover how Veristat blends deep scientific knowledge with strategic regulatory insight to guide sponsors through every stage of clinical development. Whether you're:
-
Building a regulatory strategy
-
Preparing for agency meetings
-
Advancing to pivotal Phase 3 trials
-
Planning a global marketing submission
Veristat Attendees
-
Daphne Smyth – Vice President, Global Regulatory Affairs
-
David Chia – Senior Business Development Director
-
Balma Gil – Business Development Director
Conference details
-
Event: RAPS Euro Convergence 2025
-
Dates: May 13–16, 2025 (Pre-conference Workshops: May 13)
-
Booth number 20
-
Location: SQUARE Brussels Meeting Centre, Mont des Arts/Kunstberg, B-1000 Brussels, Belgium
Schedule a Meeting
Let’s connect! Meet with our regulatory experts to explore how Veristat can help you navigate global regulatory pathways and bring your products to market faster.
Fill out the form to schedule a meeting with our team during the conference.
Learn more about the conference
https://www.raps.org/europe-2025/home
Schedule A Meeting
Meet with us at RAPS Euro Convergence 2025
10 min read
Monthly FDA Guidance and Regulatory News Review - May 2026
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...